OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Pharmacotherapy for Amyotrophic Lateral Sclerosis: A Review of Approved and Upcoming Agents
Stephen A. Johnson, Ton Fang, Fabiola De Marchi, et al.
Drugs (2022) Vol. 82, Iss. 13, pp. 1367-1388
Closed Access | Times Cited: 62
Stephen A. Johnson, Ton Fang, Fabiola De Marchi, et al.
Drugs (2022) Vol. 82, Iss. 13, pp. 1367-1388
Closed Access | Times Cited: 62
Showing 1-25 of 62 citing articles:
Current State and Future Directions in the Therapy of ALS
Laura Tzeplaeff, Sibylle Wilfling, Maria Viktoria Requardt, et al.
Cells (2023) Vol. 12, Iss. 11, pp. 1523-1523
Open Access | Times Cited: 55
Laura Tzeplaeff, Sibylle Wilfling, Maria Viktoria Requardt, et al.
Cells (2023) Vol. 12, Iss. 11, pp. 1523-1523
Open Access | Times Cited: 55
Neuromuscular organoids model spinal neuromuscular pathologies in C9orf72 amyotrophic lateral sclerosis
Chong Gao, Qinghua Shi, Pan Xue, et al.
Cell Reports (2024) Vol. 43, Iss. 3, pp. 113892-113892
Open Access | Times Cited: 16
Chong Gao, Qinghua Shi, Pan Xue, et al.
Cell Reports (2024) Vol. 43, Iss. 3, pp. 113892-113892
Open Access | Times Cited: 16
Advances in molecular pathology, diagnosis, and treatment of amyotrophic lateral sclerosis
Hristelina Ilieva, Mithila Vullaganti, Justin Kwan
BMJ (2023), pp. e075037-e075037
Open Access | Times Cited: 38
Hristelina Ilieva, Mithila Vullaganti, Justin Kwan
BMJ (2023), pp. e075037-e075037
Open Access | Times Cited: 38
Overlapping Neuroimmune Mechanisms and Therapeutic Targets in Neurodegenerative Disorders
Fabiola De Marchi, Ivana Munitić, Lea Vidatic, et al.
Biomedicines (2023) Vol. 11, Iss. 10, pp. 2793-2793
Open Access | Times Cited: 26
Fabiola De Marchi, Ivana Munitić, Lea Vidatic, et al.
Biomedicines (2023) Vol. 11, Iss. 10, pp. 2793-2793
Open Access | Times Cited: 26
Microglia and Astrocytes in Amyotrophic Lateral Sclerosis: Disease-Associated States, Pathological Roles, and Therapeutic Potential
Justin You, Mohieldin Youssef, Jhune Rizsan Santos, et al.
Biology (2023) Vol. 12, Iss. 10, pp. 1307-1307
Open Access | Times Cited: 23
Justin You, Mohieldin Youssef, Jhune Rizsan Santos, et al.
Biology (2023) Vol. 12, Iss. 10, pp. 1307-1307
Open Access | Times Cited: 23
TwinF interface inhibitor FP802 stops loss of motor neurons and mitigates disease progression in a mouse model of ALS
Jing Yan, Yumeng Wang, Andrea Hellwig, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 2, pp. 101413-101413
Open Access | Times Cited: 8
Jing Yan, Yumeng Wang, Andrea Hellwig, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 2, pp. 101413-101413
Open Access | Times Cited: 8
Sodium Phenylbutyrate and Tauroursodeoxycholic Acid: A Story of Hope Turned to Disappointment in Amyotrophic Lateral Sclerosis Treatment
Arsh Haj Mohamad Ebrahim Ketabforoush, Faezeh Faghihi, Fereshteh Azedi, et al.
Clinical Drug Investigation (2024) Vol. 44, Iss. 7, pp. 495-512
Closed Access | Times Cited: 8
Arsh Haj Mohamad Ebrahim Ketabforoush, Faezeh Faghihi, Fereshteh Azedi, et al.
Clinical Drug Investigation (2024) Vol. 44, Iss. 7, pp. 495-512
Closed Access | Times Cited: 8
From Brain to Muscle: The Role of Muscle Tissue in Neurodegenerative Disorders
Elisa Duranti, Chiara Villa
Biology (2024) Vol. 13, Iss. 9, pp. 719-719
Open Access | Times Cited: 8
Elisa Duranti, Chiara Villa
Biology (2024) Vol. 13, Iss. 9, pp. 719-719
Open Access | Times Cited: 8
Mitochondria, a Key Target in Amyotrophic Lateral Sclerosis Pathogenesis
Emmanuelle C. Genin, Mélanie Abou-Ali, Véronique Paquis‐Flucklinger
Genes (2023) Vol. 14, Iss. 11, pp. 1981-1981
Open Access | Times Cited: 20
Emmanuelle C. Genin, Mélanie Abou-Ali, Véronique Paquis‐Flucklinger
Genes (2023) Vol. 14, Iss. 11, pp. 1981-1981
Open Access | Times Cited: 20
New drug approvals for 2022: Synthesis and clinical applications
Shuo Yuan, Dandan Shen, Rui Jia, et al.
Medicinal Research Reviews (2023) Vol. 43, Iss. 6, pp. 2352-2391
Closed Access | Times Cited: 18
Shuo Yuan, Dandan Shen, Rui Jia, et al.
Medicinal Research Reviews (2023) Vol. 43, Iss. 6, pp. 2352-2391
Closed Access | Times Cited: 18
Beyond PDE4 inhibition: A comprehensive review on downstream cAMP signaling in the central nervous system
Zoë Donders, Iga Joanna Skorupska, Emily Willems, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 177, pp. 117009-117009
Open Access | Times Cited: 7
Zoë Donders, Iga Joanna Skorupska, Emily Willems, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 177, pp. 117009-117009
Open Access | Times Cited: 7
Chaperone-Dependent Mechanisms as a Pharmacological Target for Neuroprotection
М. В. Воронин, Elena Abramova, Ekaterina R. Verbovaya, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 1, pp. 823-823
Open Access | Times Cited: 16
М. В. Воронин, Elena Abramova, Ekaterina R. Verbovaya, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 1, pp. 823-823
Open Access | Times Cited: 16
Muscle Involvement in Amyotrophic Lateral Sclerosis: Understanding the Pathogenesis and Advancing Therapeutics
Elisa Duranti, Chiara Villa
Biomolecules (2023) Vol. 13, Iss. 11, pp. 1582-1582
Open Access | Times Cited: 15
Elisa Duranti, Chiara Villa
Biomolecules (2023) Vol. 13, Iss. 11, pp. 1582-1582
Open Access | Times Cited: 15
The Need for Biomarkers in the ALS–FTD Spectrum: A Clinical Point of View on the Role of Proteomics
Francesca Vignaroli, Angelica Mele, Giacomo Tondo, et al.
Proteomes (2023) Vol. 11, Iss. 1, pp. 1-1
Open Access | Times Cited: 12
Francesca Vignaroli, Angelica Mele, Giacomo Tondo, et al.
Proteomes (2023) Vol. 11, Iss. 1, pp. 1-1
Open Access | Times Cited: 12
Palliative Care in Amyotrophic Lateral Sclerosis
Sebastiano Mercadante, Lou’i Al-Husinat
Journal of Pain and Symptom Management (2023) Vol. 66, Iss. 4, pp. e485-e499
Closed Access | Times Cited: 11
Sebastiano Mercadante, Lou’i Al-Husinat
Journal of Pain and Symptom Management (2023) Vol. 66, Iss. 4, pp. e485-e499
Closed Access | Times Cited: 11
Insights into Advances and Applications of Biomaterials for Nerve Tissue Injuries and Neurodegenerative Disorders
Varsha Pai, Bhisham Narayan Singh, Abhishek Kumar Singh
Macromolecular Bioscience (2024)
Open Access | Times Cited: 4
Varsha Pai, Bhisham Narayan Singh, Abhishek Kumar Singh
Macromolecular Bioscience (2024)
Open Access | Times Cited: 4
Amyotrophic Lateral Sclerosis and Parkinson's Disease: Brain Tissue Transcriptome Analysis Reveals Interactions
Zewei Fu, Baofeng Feng, Herman Yao Akogo, et al.
Molecular Neurobiology (2025)
Closed Access
Zewei Fu, Baofeng Feng, Herman Yao Akogo, et al.
Molecular Neurobiology (2025)
Closed Access
Meroterpenoids from Terrestrial and Marine Fungi: Promising Agents for Neurodegenerative Disorders—An Updated Review
Daniela S. Dimitrova, Simeonka Dimitrova, Gabriela Kehayova, et al.
Current Issues in Molecular Biology (2025) Vol. 47, Iss. 2, pp. 96-96
Open Access
Daniela S. Dimitrova, Simeonka Dimitrova, Gabriela Kehayova, et al.
Current Issues in Molecular Biology (2025) Vol. 47, Iss. 2, pp. 96-96
Open Access
Multi-scale Neural Homeostasis Mechanisms: Insights into Neurodegenerative Diseases and Therapeutic Approaches, Including Exercise
Ya Wang, Xuhui Chen, Cuntai Zhang, et al.
Advanced Exercise and Health Science (2025)
Open Access
Ya Wang, Xuhui Chen, Cuntai Zhang, et al.
Advanced Exercise and Health Science (2025)
Open Access
Exploring Nano-Delivery Systems to Enhance the Edaravone Performance in Amyotrophic Lateral Sclerosis Treatment
Brandon Aguiar, Ana Rita Alfenim, Cláudia Sofia Machado, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 2146-2146
Open Access
Brandon Aguiar, Ana Rita Alfenim, Cláudia Sofia Machado, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 2146-2146
Open Access
Sex-Specific Markers of Neuroinflammation and Neurodegeneration in the Spinal Cord Proteome of the SOD1G93A Mouse Model of Amyotrophic Lateral Sclerosis
Liam M. Koehn, Joel R. Steele, Ralf B. Schittenhelm, et al.
Journal of Proteome Research (2025)
Closed Access
Liam M. Koehn, Joel R. Steele, Ralf B. Schittenhelm, et al.
Journal of Proteome Research (2025)
Closed Access
An Expanded Access Protocol of RNS60 in Amyotrophic Lateral Sclerosis
Grace Addy, Erica Scirocco, Dario Gelevski, et al.
Muscle & Nerve (2025)
Open Access
Grace Addy, Erica Scirocco, Dario Gelevski, et al.
Muscle & Nerve (2025)
Open Access
Changes to Average Survival of Patients With Amyotrophic Lateral Sclerosis (1995–2018)
Rosario Vasta, Filippo De Mattei, Salvatore Tafaro, et al.
Neurology (2025) Vol. 104, Iss. 8
Closed Access
Rosario Vasta, Filippo De Mattei, Salvatore Tafaro, et al.
Neurology (2025) Vol. 104, Iss. 8
Closed Access
Neuroglia in neurodegeneration: Amyotrophic lateral sclerosis and frontotemporal dementia
Fabiola De Marchi, Edoardo Gioele Spinelli, Caterina Bendotti
Handbook of clinical neurology (2025), pp. 45-67
Closed Access
Fabiola De Marchi, Edoardo Gioele Spinelli, Caterina Bendotti
Handbook of clinical neurology (2025), pp. 45-67
Closed Access
Atorvastatin, simvastatin, rosuvastatin and Amyotrophic lateral sclerosis establishing cause and effect
Min Li, Yaping Li, Xuping Yang, et al.
Research Square (Research Square) (2025)
Closed Access
Min Li, Yaping Li, Xuping Yang, et al.
Research Square (Research Square) (2025)
Closed Access
